These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 7039438)

  • 1. Inhaled atropine sulfate: dose-response characteristics in adult patients with chronic airflow obstruction.
    Pak CC; Kradjan WA; Lakshminarayan S; Marini JJ
    Am Rev Respir Dis; 1982 Mar; 125(3):331-4. PubMed ID: 7039438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of tachyphylaxis to inhaled atropine in patients with chronic obstructive pulmonary disease.
    Klaustermeyer WB; Wong SC; Kurohara ML; Gross NJ; Braun SR; Hudson LD
    Am Rev Respir Dis; 1989 Sep; 140(3):582-5. PubMed ID: 2675700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atropine and terbutaline aerosols in chronic bronchitis: efficacy and sites of action.
    Marini JJ; Lakshminarayan S; Kradjan WA
    Chest; 1981 Sep; 80(3):285-91. PubMed ID: 7023861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of inhaled atropine or metaproterenol in patients with chronic airway obstruction and therapeutic serum theophylline levels.
    Passamonte PM; Martinez AJ
    Chest; 1984 May; 85(5):610-5. PubMed ID: 6370619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of atropine methonitrate and its combination with reproterol in chronic airway obstruction.
    Macha HN; Aurich R
    Arzneimittelforschung; 1982; 32(7):774-6. PubMed ID: 6751338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose inhaled albuterol in severe chronic airflow limitation.
    Vathenen AS; Britton JR; Ebden P; Cookson JB; Wharrad HJ; Tattersfield AE
    Am Rev Respir Dis; 1988 Oct; 138(4):850-5. PubMed ID: 2462383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiopulmonary responses to exercise in chronic airflow obstruction. Effects of inhaled atropine sulfate.
    Brown SE; Prager RS; Shinto RA; Fischer CE; Stansbury DW; Light RW
    Chest; 1986 Jan; 89(1):7-11. PubMed ID: 3940792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled atropine sulfate: dose response characteristics.
    Cavanaugh MJ; Cooper DM
    Am Rev Respir Dis; 1976 Sep; 114(3):517-24. PubMed ID: 970733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response study of inhaled salbutamol powder in chronic airflow obstruction.
    Corris PA; Neville E; Nariman S; Gibson GJ
    Thorax; 1983 Apr; 38(4):292-6. PubMed ID: 6867983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of ipratropium bromide on histamine-induced bronchoconstriction in subjects with chronic airway obstruction].
    Nannini LJ
    Medicina (B Aires); 2001; 61(3):262-6. PubMed ID: 11474870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of methacholine-induced bronchoconstriction in patients with chronic obstructive pulmonary disease.
    Greenspon LW; Parrish B
    Am Rev Respir Dis; 1988 Feb; 137(2):281-5. PubMed ID: 3277497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to corticosteroids in chronic airflow obstruction: relationship to emphysema and airways collapse.
    Weir DC; Gove RI; Robertson AS; Burge PS
    Eur Respir J; 1991 Nov; 4(10):1185-90. PubMed ID: 1804665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nifedipine on salbutamol-induced bronchodilation in partially reversible airway obstruction.
    Rolla G; Arossa W; Bucca C; Bugiani M
    Int J Clin Pharmacol Res; 1986; 6(5):409-13. PubMed ID: 3781703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose response to ipratropium as a nebulized solution in patients with chronic obstructive pulmonary disease. A three-center study.
    Gross NJ; Petty TL; Friedman M; Skorodin MS; Silvers GW; Donohue JF
    Am Rev Respir Dis; 1989 May; 139(5):1188-91. PubMed ID: 2523681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of bronchodilator effects and site of action of fenoterol and ipratropium in chronic obstructive bronchitis].
    Kheir A; Ying Y; Hannhart B; Duvivier C; Peslin R; Polu JM
    Rev Mal Respir; 1993; 10(1):9-15. PubMed ID: 8451502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence.
    Easton PA; Jadue C; Dhingra S; Anthonisen NR
    N Engl J Med; 1986 Sep; 315(12):735-9. PubMed ID: 2943994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atropine and glycopyrrolate effects on lung mechanics in normal man.
    Gal TJ; Suratt PM
    Anesth Analg; 1981 Feb; 60(2):85-90. PubMed ID: 7469088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum atropine concentrations after inhalation of atropine sulfate.
    Kradjan WA; Lakshminarayan S; Hayden PW; Larson SW; Marini JJ
    Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):471-2. PubMed ID: 7224361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.